Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC

NCT04630730 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Recombinant intravesical BCG (Bacillus Calmette-Guérin VPM1002BC)
DRUG: Atezolizumab
DRUG: Cisplatin
DRUG: Gemcitabine

Sponsor

Swiss Cancer Institute